Replies to post #365227 on Amarin Corp Plc (AMRN)

[couldbebetter]

Jasbg, I have great disdain for Thero because he was a very poor CEO.
Thero took the path of dilution to pay for his sales force instead of
selling the company. (Persistent rumors at the time were that JT
had interest, but not at the numbers he wanted.) Thero did not
understand that a small biotech could not deal with the insurance
companies effectively for what should have been a low cost high
volume drug. Until BP owns this the insurance issues will persist.
That is only one problem...the other is AMRN being unable to deal
with the generic Lovasa problem which was never dealt with by Thero.
No offense intended but the man was "thick."

I do agree that the world needs this drug...sadly, AMRN in GIA mode
will not get it where it needs to be.

[Abe1234]

Dear Sir, I see that you are putting the blame on Judge Du. I would blame it on JT not judge Du. Many of us may have taken an economics class while pursuing our undergraduate and learned about the risk and benefit analysis. With one drug and nothing in pipeline, the best option was to settle with the generics. Amarin should not had gambled that in court. Our market cap right now is 1.3 Billion. We used to be a 10-Billion-dollar company. Had we settled with generics, we would be at least 5 Billion Dollar company now. If anybody is to be blamed, it is the previous management not the court system. After the disaster, I don’t know how BOD got to keep their place. Anyway, it is the past. Hopefully, Marjac prevails in the court. It is truly an achievement that we got this far in the court regardless on winning or losing. Court does see a merit in our case.

[The Canes]

After Anchor met end points Adam Feuerstein commented we’d have a challenge obtaining a patent. The stock languished. Then miraculously we succeeded in getting a patent. It really makes me wonder if we ever had a strong core of patent protection. JT was a talentless sloth. GIA and 600 sales reps that produced next to nothing was an egotistical misguided game plan. He didn’t pay a price like us. He cashed in millions of free shares. He’s no hero and never would have been. If you couple the weak patent issues with the egotistical GIA CRAP we’d all have been so much better off taking a $20 per share buyout. Now we’re praying for a Hail Mary while JT’s fishing in the French Riviera.

[ralphey]

I think we can safely say that anyone here would have gladly paid the price JT did ....